Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 04:00PM ET
88.01
Dollar change
+1.20
Percentage change
1.38
%
Index- P/E21.47 EPS (ttm)4.10 Insider Own0.01% Shs Outstand237.73M Perf Week0.14%
Market Cap20.92B Forward P/E- EPS next Y-2.02 Insider Trans0.00% Shs Float237.71M Perf Month-4.33%
Income998.75M PEG- EPS next Q-0.86 Inst Own17.85% Short Float1.29% Perf Quarter-11.82%
Sales4.12B P/S5.08 EPS this Y-148.47% Inst Trans12.40% Short Ratio4.83 Perf Half Y-5.61%
Book/sh94.08 P/B0.94 EPS next Y-2.31% ROA3.97% Short Interest3.08M Perf Year-27.23%
Cash/sh54.20 P/C1.62 EPS next 5Y- ROE4.56% 52W Range85.21 - 125.83 Perf YTD-16.61%
Dividend Est.- P/FCF3.80 EPS past 5Y- ROI4.42% 52W High-30.06% Beta0.25
Dividend TTM- Quick Ratio9.26 Sales past 5Y843.27% Gross Margin84.24% 52W Low3.28% ATR (14)2.26
Dividend Ex-DateJun 02, 2022 Current Ratio9.43 EPS Y/Y TTM-89.95% Oper. Margin22.76% RSI (14)44.27 Volatility1.86% 2.23%
Employees3082 Debt/Eq0.01 Sales Y/Y TTM-77.63% Profit Margin24.26% Recom2.37 Target Price115.47
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-78.45% Payout0.00% Rel Volume0.82 Prev Close86.81
Sales Surprise-19.12% EPS Surprise-19.93% Sales Q/Q-63.55% EarningsMay 06 BMO Avg Volume636.42K Price88.01
SMA20-1.82% SMA50-3.58% SMA200-13.20% Trades Volume528,474 Change1.38%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Initiated BMO Capital Markets Outperform $127
Jan-05-24Initiated Oppenheimer Perform
Dec-01-23Downgrade JP Morgan Neutral → Underweight $106 → $99
Oct-16-23Downgrade HSBC Securities Buy → Hold $124 → $111
Jul-14-23Initiated HSBC Securities Buy $124
May-17-23Upgrade Redburn Neutral → Buy $165 → $170
Dec-15-22Upgrade BofA Securities Neutral → Buy $239
Aug-17-22Initiated Cowen Market Perform $177
Jul-13-22Upgrade SVB Leerink Mkt Perform → Outperform
Jul-06-22Resumed Canaccord Genuity Buy $192
Today 07:21AM
Apr-22-24 06:08PM
06:45AM
Apr-07-24 02:00PM
Mar-31-24 03:39PM
09:53AM Loading…
Mar-26-24 09:53AM
06:44AM
01:00AM
Mar-25-24 06:47AM
06:19AM
Mar-21-24 11:38AM
01:43AM
Mar-20-24 04:45PM
03:56PM
03:38PM
02:45PM Loading…
02:45PM
11:05AM
10:34AM
09:20AM
09:09AM
07:49AM
06:22AM
06:17AM
06:15AM
06:15AM
06:00AM
Mar-17-24 09:19AM
08:50AM
Mar-15-24 05:53AM
Mar-14-24 01:51PM
11:07AM Loading…
Mar-13-24 11:07AM
Mar-11-24 03:29PM
07:45AM
Mar-09-24 01:09PM
Mar-08-24 01:25AM
Mar-07-24 06:45AM
Mar-06-24 04:45PM
06:45AM
Mar-05-24 04:16AM
Mar-04-24 06:42PM
05:33PM
10:06AM
Mar-02-24 10:42AM
Feb-27-24 05:45AM
Feb-26-24 12:29PM
10:27AM
Feb-23-24 01:00PM
Feb-14-24 06:35PM
Feb-08-24 06:07AM
05:45AM
Feb-04-24 06:56AM
Feb-02-24 02:39PM
Feb-01-24 06:30AM
Jan-31-24 06:45AM
Jan-25-24 09:55AM
Jan-24-24 11:30AM
Jan-22-24 06:45AM
06:45AM
Jan-17-24 11:30AM
Jan-09-24 04:16PM
07:37AM
07:12AM
07:09AM
06:52AM
06:45AM
06:45AM
Dec-28-23 12:00AM
Dec-24-23 05:34PM
Dec-21-23 08:00AM
Dec-19-23 12:31PM
09:12AM
08:35AM
Dec-18-23 01:15PM
10:06AM
05:50AM
Dec-15-23 12:02PM
Dec-12-23 03:04PM
06:45AM
Dec-08-23 10:13AM
Dec-05-23 07:59AM
Dec-01-23 05:32AM
Nov-28-23 01:34PM
01:34PM
Nov-21-23 09:04AM
05:37AM
Nov-14-23 04:17PM
Nov-09-23 10:01PM
Nov-07-23 08:39AM
05:13AM
Nov-06-23 04:30PM
04:21PM
04:03PM
01:40PM
12:48PM
12:13PM
12:13PM
11:56AM
11:00AM
10:57AM
09:34AM
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.